Xenetic Biosciences (XBIO) EBITDA Margin (2011 - 2021)
Xenetic Biosciences (XBIO) posted EBITDA Margin of -571.32% for Q4 2021, up 247.45 percentage points from -818.77% a year earlier but down 177.35 percentage points from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) EBITDA Margin (2011 - 2021) Analysis & Trends
For FY2021, Xenetic Biosciences' EBITDA Margin came in at -495.12%, up 2694.48 percentage points from FY2020.
- Annual EBITDA Margin shows a five-year change of +1084.69 percentage points (FY2016 to FY2021).
- In prior years, Xenetic Biosciences' EBITDA Margin was -3189.59% in FY2020 (+72185.66 pp), -75375.25% in FY2019 and -46.74% in FY2017 (+1533.07 pp).
- Quarterly EBITDA Margin has run from a low of -9060.68% in Q3 2020 to a high of 59.14% in Q4 2017 over five years.
- On a year-over-year basis, EBITDA Margin has increased in each of the last five quarters, with an average year-over-year change of +3443.01 percentage points over the last five quarters.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -393.97% (Q3 2021), -392.09% (Q2 2021) and -711.59% (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Xenetic Biosciences | 5.30 Mn | -20.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -571.32% |
| Sep 30, 2021 | -393.97% |
| Jun 30, 2021 | -392.09% |
| Mar 31, 2021 | -711.59% |
| Dec 31, 2020 | -818.77% |
| Sep 30, 2020 | -9,060.68% |
| Jun 30, 2020 | -869.82% |
| Mar 31, 2020 | -2,156.79% |
| Dec 31, 2019 | -7,196.74% |
| Dec 31, 2017 | 59.14% |
| Sep 30, 2017 | -2,630.00% |
| Dec 31, 2016 | -1.84% |
| Nov 30, 2012 | -18.11% |
| May 31, 2012 | -83.21% |
| Feb 29, 2012 | -57.70% |
| Nov 30, 2011 | -82.01% |
API Access
Xenetic Biosciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();